Aufdeckung von Arzneimittelrisiken nach der Zulassung: Methodenentwicklung zur Nutzung von Routinedaten der gesetzlichen Krankenversicherungen

Translated title of the contribution: Detection of drug risks after approval: Methods development for the use of routine statutory health insurance data

Ronja Foraita*, Louis Dijkstra, Felix Falkenberg, Marco Garling, Roland Linder, René Pflock, Mariam R. Rizkallah, Markus Schwaninger, Marvin N. Wright, Iris Pigeot

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'Detection of drug risks after approval: Methods development for the use of routine statutory health insurance data'. Together they form a unique fingerprint.

Medicine & Life Sciences